Home  About us  Contact
 

Lung Volume Reduction Surgery (lung + volume_reduction_surgery)

Distribution by Scientific Domains
Medical Sciences100%

Selected Abstracts

Lung Volume Reduction Surgery.

ANZ JOURNAL OF SURGERY, Issue 1-2 2004
Clifford Hughes
No abstract is available for this article. [source]

Lung volume reduction surgery: The Thoracic Society of Australia and New Zealand

INTERNAL MEDICINE JOURNAL, Issue 2 2001
G. I. Snell
Abstract Lung volume reduction surgery involves the removal of emphysematous lung tissue with the aim of palliating symptoms in selected patients with severe emphysema. This form of surgery is being practised in Australia with favourable short-term outcomes, similar to those reported in the literature. Large multicentre trials are currently underway in North America and the United Kingdom to clarify issues of safety and long-term efficacy. As a result, it is too early to apply an evidence-based approach to this procedure. In the meantime, local audits of practice need to be undertaken to define patient subgroups at higher risk of morbidity and mortality. (Intern Med J 2001; 31: 112,115) [source]

Lung volume reduction surgery (LVRS) for emphysema,early Australian experience

INTERNAL MEDICINE JOURNAL, Issue 2 2000
R. J. PIERCE
No abstract is available for this article. [source]

The six-minute walk test: a useful metric for the cardiopulmonary patient

INTERNAL MEDICINE JOURNAL, Issue 8 2009
T. Rasekaba
Abstract Measurement of exercise capacity is an integral element in assessment of patients with cardiopulmonary disease. The 6-min walk test (6MWT) provides information regarding functional capacity, response to therapy and prognosis across a range of chronic cardiopulmonary conditions. A distance less than 350 m is associated with increased mortality in chronic obstructive pulmonary disease, chronic heart failure and pulmonary arterial hypertension. Desaturation during a 6MWT is an important prognostic indicator for patients with interstitial lung disease. The 6MWT is sensitive to commonly used therapies in chronic obstructive pulmonary disease such as pulmonary rehabilitation, oxygen, long-term use of inhaled corticosteroids and lung volume reduction surgery. However, it appears less reliable to detect changes in clinical status associated with medical therapies for heart failure. A change in walking distance of more than 50 m is clinically significant in most disease states. When interpreting the results of a 6MWT, consideration should be given to choice of predictive values and the methods by which the test was carried out. [source]

Less invasive lung volume reduction surgery

ANAESTHESIA, Issue 4 2004
D. J. Viira
No abstract is available for this article. [source]